mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |